AQP5 and Infertility: The PDE4 inhibitor rolipram and the different pathways such as IL-6/NF-κB/TNFα/MAPK and cAMP/AQP5 mediating its effects against ovarian torsion damage may be a promising target for ovarian damage or infertility.